Somit Pandey

About

I am a Researcher in Nuclear Medicine and Radiopharmaceutical Sciences with expertise in developing and translating novel radiopharmaceuticals. With hands-on experience in peptide conjugation, radiolabeling, preclinical studies, and clinical trials, I am passionate about advancing precision imaging and molecular theranostics.

Employment

• Post Graduate Institute of Medical Education and Research Research Associate
  2023 - Present
• Post Graduate Institute of Medical Education and Research Senior Research Fellow
  2019 - 2023
• Post Graduate Institute of Medical Education and Research Junior Research Fellow
  2018 - 2019
• Shri Guru Ram Rai Institute of Medical and Health Sciences Intern
  2015 - 2015

Education

• Post Graduate Institute of Medical Education and Research Ph.D. Scholar
  2019 - 2025
• Indian Institute of Technology Roorkee Master of Science
  2016 - 2018
• Govind Ballabh Pant University of Agriculture and Technology Bachelor of Technology, Biotechnology
  2012 - 2018

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• Advancing Cancer Theranostics Through Integrin αVβ3-Targeted Peptidomimetic IAC: From Bench to Bedside
  Cancer Biotherapy and Radiopharmaceuticals 2024 DOI: 10.1089/cbr.2023.0140
  +Save
• 68Ga-DOTAGA-IAC PET/CT for Imaging Metastatic and Recurrent Adrenocortical Carcinoma
  Clinical Nuclear Medicine 2023 DOI: 10.1097/rlu.0000000000004497
  +Save
• 68Ga-DOTA.SA.FAPI as a Potential, Noninvasive Diagnostic Probe for Recurrent and Metastatic Adrenocortical Carcinoma
  Clinical Nuclear Medicine 2023 DOI: 10.1097/rlu.0000000000004563
  +Save
• Potential Role of 68Ga-NOTA-Duramycin PET/CT Imaging for Early Response Evaluation in a Lymphoma Patient
  Clinical Nuclear Medicine 2022 DOI: 10.1097/rlu.0000000000004462
  +Save
• Diagnostic efficacy of 68Ga-DOTAGA-Duramycin for early detection of anthracycline induced cardiotoxicity in Wistar rats
  Nuclear Medicine and Biology 2022 DOI: 10.1016/s0969-8051(22)00164-0
  +Save
• Radiopharmaceutical preparation and quality control of 225Ac-DOTAGA-IAC for tumor targeted alpha therapy (TAT)
  Nuclear Medicine and Biology 2022 DOI: 10.1016/s0969-8051(22)00311-0
  +Save
• Nuclear medicine in the management of superficial skin abnormalities and institutional experience
  Nuclear Medicine Communications 2022 DOI: 10.1097/mnm.0000000000001549
  +Save
• Cold kit for Rhenium-188 microspheres based selective intra-arterial therapy (SIRT): Preparation, characterization and feasibility study
  Applied Radiation and Isotopes 2022 DOI: 10.1016/j.apradiso.2022.110423
  +Save
• Freeze-dried microspheres for selective intra-arterial radionuclide therapy: an affordable solution
  Nuclear Medicine Communications 2020 DOI: 10.1097/mnm.0000000000001225
  +Save
• Bio-evaluation of Poly-Lactate co-Glycolic Acid (PLGA) nanoparticles loaded with radio-labeled rifampicin.
  DOI: 10.22541/au.167483886.62615946/v1
  +Save